With US government healthcare spending on a steady rise, foreign investors are turning to US healthcare in pursuit of a reliable stream of revenue. These include Russian billionaire Mikhail Fridman, who – like many investors in the Middle East – is now looking beyond oil for viable investment opportunities.
Along with three fellow Alfa Group billionaires, Fridman plans to invest up to 3 billion USD into healthcare over the next three years.
“There are signals of a major tectonic shift in economic development happening before our eyes,” said Fridman. “Innovations in technology, biology, and genomics are changing the way we think about healthcare treatments. This enables us to look at healthcare in new and unique ways.”
Like many Middle Eastern investors, Fridman prefers actively investing in projects and having a hand in their development, rather than investing in hedge funds and simply waiting for a return. However, while Fridman and his associates are relying on the help of two Washington insiders to help them implement their US investment plans, Middle Eastern investors are more likely to turn to trusted advisors and facilitators who are familiar with the US market.
Naseba is a deal facilitator with offices in Dubai, Chicago and Bangalore, and a presence in many other countries globally. We have spent over a decade building a network of contacts with investors from around the world – including the Middle East. This network includes family offices, sovereign wealth funds, investment firms, high net worth individuals and members of royalty.
Our investor analyst team speaks to investors on a daily basis in order to fully understand their needs and mandates. The team is currently sourcing high-potential, innovative US healthcare investment opportunities on behalf of these investors.
On 4th and 5th, October 2016, we will be organising a private investor meeting in Dubai and Riyadh to introduce pre-screened Middle Eastern investors to pre-qualified US healthcare investment opportunities.
Submit your business case:
Oops! We could not locate your form.
To learn more, contact:
Naseba investor introduction
+971 4 455 7954